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Transcriptional analysis of cleft
palate in TGFβ3 mutant mice
J. Liu1,4, S. K. Chanumolu2,4, K. M. White3, M. Albahrani2, H. H. Otu2 & A. Nawshad1*
Cleft palate (CP) is one of the most common craniofacial birth defects, impacting about 1 in 800
births in the USA. Tgf-β3 plays a critical role in regulating murine palate development, and Tgf-β3
null mutants develop cleft palate with 100% penetrance. In this study, we compared global palatal
transcriptomes of wild type (WT) and Tgf-β3 −/− homozygous (HM) mouse embryos at the crucial
palatogenesis stages of E14.5, and E16.5, using RNA-seq data. We found 1,809 and 2,127 differentially
expressed genes at E16.5 vs. E14.5 in the WT and HM groups, respectively (adjusted p < 0.05; |fold
change|> 2.0). We focused on the genes that were uniquely up/downregulated in WT or HM at E16.5
vs. E14.5 to identify genes associated with CP. Systems biology analysis relating to cell behaviors
and function of WT and HM specific genes identified functional non-Smad pathways and preference
of apoptosis to epithelial-mesenchymal transition. We identified 24 HM specific and 11 WT specific
genes that are CP-related and/or involved in Tgf-β3 signaling. We validated the expression of 29 of the
35 genes using qRT-PCR and the trend of mRNA expression is similar to that of RNA-seq data . Our
results enrich our understanding of genes associated with CP that are directly or indirectly regulated
via TGF-β.
Orofacial clefting is the most common craniofacial anomaly treated in pediatric hospitals and is the second most
common birth defect, with a prevalence ranging from 1/500 to 1/2,500 in humans1,2. Formation of a confluent
palate is a precise orchestration of many palatal cellular processes, including cellular movement, cell death, and
cell cycle progression3,4. Many genes have been implicated in the etiology of cleft palate (CP). Transforming
growth factor-beta (Tgf-β) isoforms (1, 2, and 3) are essential for proper development, including palate f usion5,6.
The roles of TGF-β in palatogenesis, participating in different phases of palate development, such as elevation,
contact, and fusion, have been detailed p
 reviously3. A number of studies suggest that TGF-β3 is a candidate
gene for causing cleft palate in mice2, chickens7, and humans8. The Tgf-β3 homozygous knockout (stated as
homozygous, HM in this study) mouse model presents the phenotype of CP but no other major a nomalies9.
The process of palatogenesis is remarkably similar among vertebrates. In mice, the palatal shelves grow out
bilaterally from the internal surfaces of the maxillary processes (~ E11.5). The shelves first vertically elongate
on either side of the tongue (~ E12.5) and then elevate, becoming horizontal above the tongue as the tongue
descends (~ E13.5). When the opposing shelves approach each other, the cells of the outer layer (periderm)
covering the medial edge epithelia (MEE) slough off (~ E14,0), exposing the lateral surfaces of the underlying
basal MEE cells to close contact with each other (also known as “adherence” or “fusion”), promoting formation
of the midline epithelial seam (MES) (~ E14.5; Fig. 1A–C). The palatal epithelial seam subsequently disintegrates
and reaches complete palatal mesenchymal confluency (by ~ E16.5; Fig. 1G,H). This process is governed by
epithelial mesenchymal transition (EMT) and/or apoptosis4, resulting in the mesenchymal portion of the two
palatal shelves becoming continuous.
While both the wild type (WT) and HM palates proceed through the exact same stages of palatogenesis
until E14.0 (i.e., growth, elongation, and elevation), the persistence of periderm on the Tgf-β3 HM palates at the
final “adherence/fusion” stage at E14.5 hinders palatal MEE contact between opposite palatal shelves (~ E14.5,
Fig. 1D–F) resulting in palatal cleft (Fig. 1I, J). It is evident that the MEE contact is strictly regulated by Tgf-β3 in
WT to ensure desquamation of the periderm for immaculate f usion10,11. The absence of Tgf-β3 fails to facilitate
desquamation of the periderm and hinders fusion resulting in subsequent palatal cleft in HM. Therefore, in this
study, we aim to assess the difference in the temporal gene expression for the WT and Tgf-β3 HM samples from
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Figure 1.  Histological illustration of murine palate formation in WT (A–C, G, H) and TGFβ3 −/− (HM) mice
(D–F, I, J). At 14.5 dpc, in WT palates the mid-palate region shows a complete union of a two-cell thick, basal
medial edge epithelium (MEE), consisting of two opposite palates forming a tight epithelial seam in low (A) and
higher magnifications (B); (C, yellow arrow). At 14.5 dpc, the HM (TGFβ3 −/−; D–F) palates demonstrate a
trapped additional layer of flattened epithelium between the MEE of opposite palatal shelves (D); (E); (F, green
arrow) [Figs. A–F are from J. Cell. Physiol. 230: 1,212–1,225, 2015. Wiley Periodicals, Inc., copyright John Wiley
& Sons, Inc.]. At 16.5 dpc, the WT palates show complete disintegration of the seam and palatal mesenchymal
confluence (G), higher magnification (H, red arrow). At 16.5 dpc, TGFβ3 −/− (HM) palates fail to fuse (I),
higher magnification (J), and drift apart as face continues to grow, resulting in cleft palate consequently. In the
HM palates at 16.5 dpc, the palatal epithelia are stratified (J, blue arrow).

E14.5 to E16.5 to provide further understanding of genes functionally regulated by TGF-β3 during murine palatal
fusion and examine their contribution to the development of CP using our previously established RNA-seq data12.
Several studies have explored CP-related genes using RNA-seq in murine and human CP s amples13–15, however, downstream molecular mechanisms directly and indirectly controlled by Tgf-β3 signaling remain largely
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unexplored. We previously used RNA-seq to obtain the transcriptome of WT and Tgf-β3 HM mice at crucial
stages of palatogenesis (E14.5 and E16.5)12. However, our previous study was confined to only assessing the
expression profile of the 322 known CP genes in our RNA-seq dataset and did not explore the genes differentially
expressed between the WT and HM groups and/or between the E14.5 and E16.5 time points. In this study, using
the same RNA-seq data established in our previous paper, we applied new and advanced data quality control,
filtering, quantification, normalization, differential expression, and systems biology approaches that were not
previously employed, and explored all of the differentially expressed genes across all of the genotypes and time
points. This way, we could identify potential key molecular components and possible underlying mechanisms
of palate formation during development, failure of which may result in CP.
In particular, we identified the differentially expressed genes between genotypes (at a given time point) as
well as the differentially expressed genes that changed temporally from E14.5 to E16.5 (for a given genotype).
We further applied a comparative temporal transcriptome analysis of Tgf-β3 WT and HM mice and identified
genes that were uniquely regulated by each genotype, which may contribute to CP formation in HM mice. Our
systems biology analysis based on the Gene Ontology (GO) and Ingenuity Pathway Analysis (IPA; QIAGEN Inc.,
https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis) platforms identified the biological functions, molecular networks, and regulatory pathways (especially in relation to TGF-β signaling) for the
differentially expressed genes. Finally, we validated the RNA-seq analysis results with real-time quantitative
polymerase chain reaction (qRT-PCR) for 29 genes that are either known CP-related genes and/or genes that
are regulated by TGF-β and fall under its downstream signaling pathways. For all of the 29 genes, the degree and
direction of differential expression based on RNA-seq analysis agreed with the qRT-PCR results. Collectively, this
data will enrich our understanding of TGF-β signaling during palate development and provide insight into the
temporal regulation of downstream TGF-β-regulated genetic modulators that control cell morphology, cellular
differentiation, apoptosis, and morphogenesis of the embryo.

Results

Our previously acquired RNA-seq d
 ata12 involving wild type and Tgf-β3 homozygous knockout mouse models
on E14.5 and E16.5 represented four sample groups (denoted as “WT14.5,” “WT16.5,” “HM14.5,” and “HM16.5”),
each represented by two biological replicates (denoted as “a,” or “b”) for a total of eight samples. The average
read count for the raw RNA-seq data was ~ 65.5 M paired-end reads (i.e., ~ 130.1 M total reads) per sample providing a high coverage of the transcriptome. The re-analysis of this data involved data trimming and filtering,
normalization, expression quantification, clustering, differential analysis, comparative analysis, systems biology
analysis, and qRT-PCR validation.

RNA‑seq data processing and clustering. After trimming and filtering, the number of average total
reads per sample came down to ~ 128.1 M (Supplementary Fig. 1A). The average read length was 101 bp in the
raw data, which decreased to 95.86 bp following trimming and filtering (Supplementary Fig. 1B). On the other
hand, the average Phred read quality score increased to 36.79 from 35.84 (Supplementary Fig. 1C); and the
percentage of high-quality bases (bases with a quality score > 20) per sample increased to 99.20% from 96.28%
(Supplementary Fig. 1D) following trimming and filtering. Therefore, both the total number of reads and the
average read length parameters showed small changes in quantity after trimming and filtering; but this resulted
in significant data quality improvement.
RNA-seq analysis generated expression data for 103,215 transcripts. Transcripts that showed a TPM value of
less than 1 in both samples in all of the four groups were eliminated from downstream analysis leaving 52,475
transcripts. Biological replicates showed high degree of correlation (r > 0.98). In Supplementary Fig. 2, we show
the hierarchical clustering of the samples using all 52,475 transcripts. This global unsupervised grouping reveals
that the samples were separated clearly by time as there are two main clades where one clade only consists of
E14.5 samples and the other clade only consists of E16.5 samples. The effect of genotype on the transcriptional
profiling was subtle because in the clustering tree we do not see a grouping based on the genotype neither globally, nor within a time point. Hence, there is a need for supervised analysis methods to identify the differences
in gene expression due to genotypic variance. Furthermore, the height of the branching points in Supplementary
Fig. 2 both for the E14.5 and E16.5 sample groups implied that the similarity between the WT and HM groups
was higher at E14.5 than it was at E16.5. This is because of the shorter branch lengths among samples in the E14.5
clade compared to the branch lengths among samples in the E16.5 clade. Therefore, the samples at E16.5 showed
a more divergent transcriptional profile and thus the effects of Tgf-β3 knockout were more pronounced at E16.5.
Differential expression analysis. Differential expression analysis also showed the stark temporal dif-

ference in gene expression between samples (Table 1). There were 4,115 and 5,304 significantly differentially
expressed genes (SDEG) between the E16.5 and E14.5 time points for the WT and HM samples, respectively
indicating that the temporal transcriptional change in HM samples was more widespread than in normal controls. Furthermore, in both genotypes, the number of upregulated genes with time (2,421 for WT and 3,153 for
HM) was more than the number of downregulated genes (1,694 for WT and 2,151 for HM) showing that transcriptional induction overshadowed transcriptional silencing. This difference in up/downregulation was further
emphasized when we applied a 2.0-fold change (FC) cutoff (on top of the adjusted p < 0.05 cutoff) to define
SDEGs. Most of the upregulated genes survived this FC cutoff (1,675 out of 2,421 in WT and 1,936 out of 3,153
in HM had an |FC|> 2.0); but the number of SDEG that were downregulated decreased dramatically (134 out
of 1,694 in WT and 191 out of 2,151 in HM had an |FC|> 2.0). This further underlined the trend of significant
transcriptional induction with time.
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Figure 2.  Hierarchical clustering of 501 (429 + 72) WT-specific and 819 (690 + 129) HM specific genes with
the color bar showing the row z-score. (A) Comparison of significantly differentially expressed genes (SDEGs)
between E16.5 and E14.5 in the WT and HM groups. WT-Specific Up ( WSU): genes uniquely upregulated in
the WT group at E16.5; WT-Specific Down ( WSD): genes uniquely downregulated in the WT group at E16.5;
HM-Specific Up (HMU): genes uniquely upregulated in the HM group at E16.5; HM-Specific Down ( HMD):
genes uniquely downregulated in the HM group at E16.5, (B) hierarchical clustering of all four groups (eight
samples) using the 501 (429 + 72) WT-specific and 819 (690 + 129) HM-specific genes identified in (A), (C)
Significantly enriched Gene Ontology (GO) categories in the WT-specific and HM-specific gene lists (sample
genes in the groups are shown), fold change of relevant WT- and HM-specific genes.
We observed a very subtle difference between the two genotypes at a given time point. At days E14.5 and
E16.5, there were only 13 and 38 SDEGs between the WT and HM samples, respectively. In concordance with
the unsupervised hierarchical clustering results, we saw a greater difference between the genotypes at E16.5. This
was further strengthened by observing 13 SDEGs between the two genotypes with an |FC|> 2.0 at E16.5, while
there were no SDEGs between the WT and HM samples with an |FC|> 2.0 at E14.5.

WT specific and HM specific gene identification. Since a direct comparison between the HM and WT

groups yielded a very subtle difference, we defined the effect due to Tgf-β3 knockout by comparing the temporal
SDEGs in the two groups. Following our adjusted p < 0.05 and |FC|> 2.0 cutoffs, we compared the 1,675 and
1,936 SDEGs that were upregulated in E16.5 vs. E14.5 in the WT and HM groups, respectively. We identified
429 genes that were upregulated in the WT group, but not in the HM group; similarly, we identified 690 genes
that were upregulated in the HM group, but not in the WT group. Conversely, we compared the 134 SDEGs
downregulated in E16.5 vs. E14.5 in the WT group with the 191 SDEGs downregulated in E16.5 vs. E14.5 in
the HM group. We identified 72 genes that were downregulated in the WT group, but not in the HM group and
similarly we identified 129 genes that were downregulated in the HM group, but not in the WT group. These
results are summarized in Fig. 2A. We called the 501 (429 + 72) SDEGs uniquely up/downregulated in the WT
group “WT specific”; and similarly, we called the 819 (690 + 129) SDEGs uniquely up/downregulated in the HM
group “HM specific.”
In Fig. 2B, we show the hierarchical clustering of the 1,320 (501 + 819) WT and HM specific SDEGs across
the four sample groups. This visual representation of expression values (heatmap) clearly shows how WT specific
genes are significantly up/downregulated between WT E14.5 and WT E16.5 samples, whereas the expression
of these genes remains “not significantly altered” between the HM E14.5 and HM E16.5 samples. A similar (but
complementary) observation holds for the HM-specific genes. Figure 2B also shows the sample similarity based
on genes specific to the genotypes, which clustered the biological replicates together and grouped the samples
in E14.5 under the same clade. This implies that the temporal difference in the dataset was more dominant than
the genotypic difference as we do not see samples from the same genotype in the two different time points group
together. The HM samples at E16.5 stood out as a distinct group, which is reasonable as the phenotypic difference
between the genotypes was not visible at E14.5 but emerged clearly at E16.5, making the HM samples at E16.5
a distinctly separate phenotypic group among the four.
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Functional analysis. In order to understand the genes and corresponding signaling network and functional mechanisms that would explain the differences observed between HM and WT samples across E16.5
and E14.5 time points, we highlighted the GO functional categories and KEGG pathways that were statistically
significantly enriched in the WT and HM specific gene lists (Fig. 2C). A complete list of SDEGs, enriched GO
categories and KEGG pathways can be found in the Supplementary Data. In Table 2, we list 24 HM-specific and
11 WT-specific genes based on their functional relevance by any one or more of the following criteria: (1) falling
under the TGF-β signaling pathway, (2) contributing to palatogenesis or cleft palate in mice, (3) being involved
in palatal cellular processes, such as EMT, apoptosis, differentiation, proliferation that are functional in palatal
and craniofacial morphogenesis, and (4) being directly or indirectly regulated by TGF-β signaling.
Systems biology analysis. Using IPA, we analyzed the signaling networks and crosstalks amongst the
downstream molecules that could be uniquely functional in WT and HM palates. Our network analysis results
suggest that the TGF-β, ERK/MAPK, p38MAPK and PI3K/AKT pathways directly regulate p38MAPK in WT
(Fig. 3A and Supplementary Fig. 3), which is not the case in HM (Fig. 3B and Supplementary Fig. 7). The canonical pathway analysis using IPA further strengthened this observation when we specifically considered the TGF-β
signaling pathway separately for WT specific genes (Fig. 3A) and for HM specific genes (Fig. 3B). Furthermore,
we showed that Goosecoid (Gsc) is downregulated by TGF-β signaling in WT (Fig. 3A), whereas, in the HM,
TGF-β signaling downregulates transcription factor Tlx2 (Fig. 3B). Finally, our results suggest that, in both in
WT and HM, TGF-β signaling regulates expression of neither Smads nor of transcripts encoding proteins that
act upstream or downstream of Smads (Fig. 3A,B; Supplementary Figs. 3 and 7).
We identified WT specific genes that are also TGF-β downstream target genes. When we overlaid the Epithelial Mesenchymal Transition (EMT) functional category on these genes, we observed that only two genes were
selected (Supplementary Fig. 4a). When we similarly overlaid the “cell death” functional category on the same
gene list, we observed nine selected genes (Supplementary Fig. 5a). These results potentially demonstrate that
in WT, TGF-β signals to regulate “cell morphology” and “differentiation” that facilitate apoptosis over EMT as
the number of TGF-β downstream target genes are predominantly pro-apoptotic genes but not EMT. We further
analyzed the mechanistic networks generated by IPA that involve TGF-β signaling. These networks show the
interaction among upstream regulators that best explain the changes observed in the SDEG list. We performed
this analysis for WT specific genes and found that these upstream regulators were predominantly pro apoptotic,
(12 out of 14, Supplementary Fig. 5b) not EMT (none out of 14, Supplementary Fig. 4b) genes.
qRT‑PCR validation. We further assessed the expression levels of the 29/35 differentially expressed genes
listed in Table 2 using real-time qRT-PCR. Our qRT-PCR results were all in agreement with our RNA-seq results
(Table 2), which demonstrated that in WT, Cdh1, Ocln, F2rl1, and Tnfrsf11b were uniquely upregulated (folds
of increase: 4.19, 5.84, 4.97, and 3.39, respectively) while Fndc3c1, Dlx1, and Gas2 were uniquely downregulated
(folds of increase: − 8.99, − 6.89, and − 7.18, respectively) at E16.5 when compared to E14.5 (Fig. 4A). Similarly,
in HM palates, genes that uniquely showed upregulation at E16.5 in RNA-seq data (Table 2), including Chrng,
Col2a1, Col11a1, Col11a2, L1cam, Adam12, Fas, Hspg2, Lox, Itgb4, Klf5, Cldn1, and Nrcam, exhibited significantly increased mRNA expression in qRT-PCR (folds of increase > 4.02), when compared to E14.5 (Fig. 4B).
Similarly, qRT-PCR results verified that Wnt9b, Alx4, Pax1, Kcp, Msx1, Ppp1r17, Twist1, and Wnt5a were also
in concordance with RNA-seq data, presenting downregulated mRNA expression (folds of decrease <  − 4.99)
uniquely in HM (Fig. 4B).

Discussion

All isoforms of TGF-β are involved in both palatal epithelial and mesenchymal cell proliferation, differentiation,
transformation, and apoptosis16. TGF-β3 plays a distinctive role in periderm removal, palatal fusion and seam
disintegration chronologically that involves crosstalk and reciprocal signaling between the two cell populations
by epithelial-mesenchymal interaction (EMI)17,18, which cannot be achieved by other isoforms10,11. Therefore, in
this study, we analyzed Tgf-β3 HM whole palates to accurately explain the global TGF-β3 signaling during palate
development. Usage of both epithelial and mesenchymal cells is a standard practice as previously done19,20. In
one of the most elegant studies of the palatal transcriptome analysis by NIH Facebase consortium, the authors
also used regions of palate with a combination of both palatal epithelia and m
 esenchyme13.
Our differential expression analysis showed a very subtle difference between the WT and HM palates—there
were only 13 and 38 SDEGs between the WT and HM samples, respectively, at days E14.5 and E16.5 (see Supplementary Data). In agreement with the unsupervised hierarchical clustering data, we noticed a greater difference
between the genotypes at E16.5. This difference was not only in numbers but also in the degree of differential
expression. When the |FC|> 2.0 cutoff was employed, there were no SDEGs at E14.5 and only 13 SDEGs at E16.5
between the HM and WT groups (Table 1). This observation may be attributable to the obvious phenotypical
difference, a palatal cleft at E16.5 and no difference at E14.5. Interestingly, 9 out of the 13 SDEGs in HM vs. WT
at E16.5 were epithelial-specific genes with a majority of them being involved in palate deformities and cleft
palate (Table 3). Henceforth, the differences between these two genotypes mainly impacted palatal epithelial
cell-specific function, which is in accordance with the expression of TGF-β3 in WT or lack of it in HM.
The subtle difference in gene expression at a given time point is likely to trigger larger downstream changes
through direct and/or indirect regulatory signaling that results in a phenotypic difference. Such a large effect
would be observed through variations in the temporal gene expression patterns for the two genotypes, which
also accounts for any subtle cell population differences as direct comparisons between the genotypes are not
involved. Therefore, we focused on genes that show temporal changes in WT (from E14.5 to E16.5) due to the
presence of Tgf-β3, which are not identified as changed in HM (from E14.5 to E16.5) due to the absence of Tgf-β3
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Comparison

Group
WT

Between time points
HM
E14.5
Between genotype
E16.5

Gene list

No. of SDEG

No. of SDEG (|FC|> 2.0)

Up in WT E16.5 versus WT E14.5

2,421

1,675

Down in WT E16.5 versus WT E14.5

1694

134

Up in HM E16.5 versus HM E14.5

3,153

1,936

Down in HM E16.5 versus HM E14.5

2,151

191

Up in HM E14.5 versus WT E14.5

8

0

Down in HM E14.5 versus WT E14.5

5

0

30

10

8

3

Up in HM E16.5 versus WT E16.5
Down in HM E16.5 versus WT E16.5

Table 1.  Significantly differentially expressed genes (SDEG), multiple hypothesis testing corrected
p value < 0.05, across time and genotype points listed separately for up/downregulation (FC, fold change).

and vice versa. In order to identify genes that show temporal difference uniquely in the WT or HM groups, we
identified WT specific and HM specific gene lists (Fig. 2A). The functional analysis of these gene lists (Fig. 2C,
Supplementary Data) render GO categories and KEGG pathways that are statistically significantly enriched in
the WT or HM, such as the “apoptotic process,” “cell adhesion molecules (CAMs),” and “focal adhesion.” These
lists show specific signaling pathways and TGF-β downstream molecules modulating both the epithelial and
the mesenchymal cellular functions that are unique to WT and HM, resulting in immaculate palatogenesis in
WT but cleft in HM.
In the Supplementary Data, we also list the 1,308 genes commonly up/down regulated between E16.5 and
E14.5 both in WT and HM groups. The rationale behind the table is to describe the common genes that are
responsible for phases that are common in both WT and HM, such as palatal cell proliferation, differentiation,
transformation and apoptosis. These cellular changes are ongoing in both genotypes, hence, the genes listed in
this Supplementary Data represent a common palatal cellular behavior and function that may not necessarily
imply genes that can trigger cleft palate. Of note among commonly upregulated genes are Sntn, which participates
in cell growth/maintenance and is involved in cell communication process in the n
 asopharynx21, and Tmem212,
which codes for a transmembrane protein known to interact with transcription factor Tcf12, an important paralog of Tcf422 and Forkhead box k2 (Frk2). Frk2 is an important regulator palatal cell proliferation via activation
of the phosphoinositide 3-kinase/AKT pathway23. Other genes to names are, Ppp1r32, which is a substrate for
cGMP-dependent protein kinase and is involved in central nervous system development and intracellular signal
transduction24, is upregulated in both WT and HM palates. It implements protein serine/threonine phosphatase
inhibitor activity and inhibits phosphatase activities of protein phosphatase 1 (Pp1) and protein phosphatase 2A
(Pp2A) complexes. Pp1 and Pp2A were reported by Weston et al.25 to account for virtually all detectable serine/
threonine protein phosphatase activity during the development of embryonic palate. We also observed common upregulation of Tspan1 and 33 in both WT and HM going from E14.5 to E16.5. Tspan1have been shown
to play crucial roles in biologic processes including cell adhesion, proliferation, differentiation, and migration26.
Our data suggest that the role of Tspans may be limited to cellular proliferation and differentiation via Smad
pathways. Another commonly upregulated transcript is Tnfrsf11a (RANK), which is a key regulator of bone
homeostasis27. As early as E14.5, mesenchymal condensations undergo chondrogenesis initially and ultimately
membranous ossification that give rise to the hard palate28. We expect the palatal cells express RANK to regulate
osteoclast function in palatal bone formation in both genotypes. In terms of epithelial markers, Krt13, which has
been shown to be expressed in the suprabasal layer of stratified palatal keratinized e pithelia29, is also among the
commonly upregulated transcripts. Krt4, a type II cytokeratin, is specifically expressed in differentiated layers
of all of oral mucosal epithelia along with family member Krt1330. Similar to Krt13, Krt4 is also upregulated in
both WT and HM. Showing a similar expression pattern to Krt13 among commonly upregulated transcripts is
Sprr3 (aka Loricrin), a marker for terminally differentiated keratinized and non-keratinized oral m
 ucosa31. This
is potentially due to the fact that palatal epithelia undergo significant stratification with terminally differentiated
keratinized epithelia covering the oral side of the palatal lining in both WT and HM palates.
Using IPA, we identified several novel findings which may suggest, and potentially imply, new signaling network molecules as well as cellular functions. Our data suggests that TGF-β signaling may induce palatogenesis
through regulating p38MAPK in WT palates (Fig. 3A,B, Supplementary Figs.3 and 7). These findings are in
agreement with previous work32–34 showing p38MAPK activation by TGF-β signaling during palatogenesis. It
has been previously demonstrated that in palatogenesis TGF-β3 signals through the SMAD pathway35–38. Our
results indicate no change in SMADs and its down- and up-stream genes at the mRNA levels both for WT and
HM palates (Fig. 3A,B, Supplementary Figs. 3 and 7). This observation does not necessarily imply an inactivation
of the SMAD pathway as transcriptional level activity does not always imply protein level functionality. On the
other hand, these results may imply non-Smad pathways to be also at play both in the WT and HM while in HM,
unlike WT, this signaling cascade does not include p38MAPK (Supplementary Figs. 3 and 7).
Uniquely in the WT palate, Goosecoid (Gsc), a homeobox-containing gene, is downregulated by TGF-β signaling in palatogenesis (Fig. 3A). Gsc mutant mice display defects in the pharyngeal muscles and the pharyngeal
mucosa39. TGF-β signaling is known to promote EMT by regulating the Gsc gene during embryonic Spemann’s
organizer formation40 as well as breast cancer metastasis41. Since GSC is known to be a homeobox transcription
factor that promotes EMT, it is likely that apoptosis is favored for seam disintegration since an EMT gene, such
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Gene name

Adjusted p value

Fold change (HM E16.5/HM E14.5)

Function

24,330

Col11a2*

1.72E−27

6.16

Variants involved in CP58,59

27,966

Col11a1*

2.63E−24

3.71

Variants involved in CP58,59

32,060

Cryab*

5.97E−10

3.44

EMT regulator60,61
Apoptosis inhibitor62,63

54,555

Adam12*

2.26E−19

2.9

TGFβ-induced EMT regulator64
TGFβ signaling modulator65
Epithelial cell proliferation and apoptosis regulator66

22,483

Col2a1*

3.50E−06

2.68

Mutations involved in cleft palate58,59

31,391

L1cam*

1.59E−04

2.38

Apoptosis resistance67
EMT regulator68
Cell adhesion69

26,253

Chrng*

1.40E−02

2.21

Mutations associated with cleft palate70

5,148

Klf5

1.17E−03

2.19

Epithelial proliferation promotor71
Apoptosis inhibition72

22,037

Clu*

4.54E−05

2.18

TGFβ signaling modulator73
Apoptosis inhibitor74
TGFβ-induced EMT regulator75

24,529

Lox*

3.14E−06

2.15

EMT regulator76,77
TGFβ signaling target78

20,598

Nr-cam*

8.95E−03

2.15

Cell proliferation and motility stimulator79

24,778

Fas*

4.34E−03

2.1

EMT inducer80
Apoptosis mediator81,82

28,763

Hspg2*

2.78E−04

2.03

TGFβ signaling target83

22,512

Cldn1*

1.32E−03

2.01

EMT promotor84,85
Apoptotic regulator86,87

20,758

Itgb4

4.08E−03

2

EMT promotor88
Epithelial Cells mobility enhancer89,90
Apoptosis inhibitor91

35,799

Twist1*

2.85E−13

− 2.17

CLP candidate gene92,93
EMT marker94–96
TGFβ signaling regulator96,97

28,019

Pdgfc

1.74E−09

− 2.21

CP candidate gene1,98,99
TGFβ signaling target100

21,994

Wnt5a*

4.44E−04

− 2.48

TGFβ signaling crosstalk101–103
EMT mediator104,105

2,930

Ppp1r17

2.98E−02

− 2.52

Embryonic palate development regulator25

48,450

Msx1

6.95E−10

− 2.66

CP candidate gene106–108
EMT mediator109
TGF-β superfamily pathways regulator106

40,310

Alx4

2.16E−13

− 2.67

CP candidate gene110
EMT mediator111,112

59,022

Kcp

7.83E−10

− 2.67

TGF-β superfamily pathways regulator113

37,034

Pax1

3.22E−03

− 2.77

Embryogenesis regulator114
Apoptosis and differentiation inducer115–117

18,486

Wnt9b

3.59E−05

− 4.88

CLP candidate gene118,119
Facial outgrowth and fusion promoter120
Cell proliferation, differentiation and cell polarity regulator121,122

ENSEMBLE gene ID

Gene name

Adjusted p value

Fold change (WT E16.5/WT E14.5)

Function

21,638

Ocln*

5.78E−10

2.84

Tight junction component123
Adhesion, apoptosis, differentiation and homeostasis regulator in
keratinocytes124

27,858

Tspan2*

2.86E−07

2.49

Cell adhesion, proliferation, differentiation and migration regulator26
TGF-β signaling downstream effector26

21,678

F2rl1*

1.73E−03

2.26

TGF-β signaling target125,126
Cell proliferation enhancer127,128

42,228

Lyn*

1.37E−07

2.17

EMT mediator129
Apoptosis inhibitor130
TGF-β signaling target131

303

Cdh1*

5.24E−03

2.09

CLP candidate gene5,132,133

63,727

Tnfrsf11b

3.11E−03

2.04

TGF-β signaling pathways mediator134,135

21,614

Vcan*

4.85E−30

− 2.66

Cell proliferation, adhesion and apoptosis regulator136,137
Apoptosis inhibitor138,139

28,487

Bnc2

3.05E−05

− 2.76

Embryonic craniofacial mesenchymal cell multiplication regulator140

30,498

Gas2

8.17E−05

− 3.06

Cell cycle and apoptosis regulator141
TGF-β signaling pathways target142

ENSEMBLE gene ID
HM specific

WT specific

Continued
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ENSEMBLE gene ID

Gene name

Adjusted p value

Fold change (WT E16.5/WT E14.5)

Function

41,911

Dlx1*

7.45E−09

− 3.25

Craniofacial patterning controller143
TGF-β signaling pathways inhibitor144,145

33,487

Fndc3c1

2.04E−21

− 4.58

Ectoderm differentiation gene146

Table 2.  Selected genes that are uniquely significantly differentially expressed (adjusted p value < 0.05) in the
HM or WT groups. CP, Cleft Palate; CL, Cleft Lip; CLP, Cleft Lip and Palate; identified in mouse or in human
(*).
as Gsc is downregulated in WT palates. Similarly, uniquely in the HM, Tgf-β signaling downregulates a separate
homeobox gene, Tlx2, a transcription factor (Fig. 3B). The Tlx2 gene encodes transcription factors essential in
the development of neural-crest-derived cells suggesting a physiological role in the transcription-factor cascade
underlying the differentiation of neuronal lineages during embryogenesis42. We did not find any direct relationship between TGF-β and Tlx2 but based on the fact that Tlx2 is crucial for neural-crest-derived cell development,
it is therefore likely that palatal epithelia (which is an ectoderm derived cell) has limited or no role for Tlx2 and
therefore it is downregulated.
Our upstream regulator analysis identified targets of Tgf-β in the WT specific gene list. Exploring the involvement of these genes in the EMT and cell death mechanisms revealed limited involvement (Cdh1 and Lef1) of
the EMT pathway (Supplementary Fig. 4a) whereas nine apoptotic genes (Ace, Cdh1, Dcn, Dlx2, Krt18, Pparg,
Rasgrp, Sema7a, and Tnfrsf11b) were directly regulated by TGF-β (Supplementary Fig. 5a). We also identified
mechanistic networks, which are interaction networks of upstream regulators that explain the changes observed
in the WT (or HM) specific genes. When we explored the functional characteristics of these interconnected
upstream regulators, none of the genes were involved in the EMT (Supplementary Fig. 4b); and 12 out of 14
genes were involved in “cell death” (Supplementary Fig. 5b).
We identified genes regulated by Tgf-β3 in WT specific genes and showed that among these Tgf-β3 targets,
Cdh1 is upregulated and Lef1 is downregulated (Supplementary Fig. 6). Loss of Cdh1 is a key marker of E
 MT43;
and the expression of Cdh1 can be repressed by the transcription factor Lef1 in palatal E
 MT22,44. Additionally,
anti-EMT cell–cell adhesion genes (Cdh1, Ocln, Tspan2) are upregulated, which may suggest a potential relationship between Tgf-β3 signaling and suppression of palatal EMT. These findings may indicate two possible
outcomes: (a) since palatal seam disintegration is complete at E16.5, the EMT markers are no longer expressed,
or (b) EMT may not be a mechanism of palatal seam disintegration. Our findings, based on mechanistic network
and upstream regulator analysis (Supplementary Figs. 4a, 4b, 4a, 4b, and 4), suggest that the latter is more probable as the number of apoptotic regulatory network genes are significantly more than the number of EMT genes.

Conclusion

Identifying transcripts that play key roles in regulating palatal development in critical stages has been a powerful approach to understanding how Tgf-β3 controls normal palatogenesis and how the lack of signaling (and its
downstream signaling partners) is associated in induction of cleft palate. This study identifies potential CP-related
genes based on differential expression between genotypes and gestational ages. The data presented in this work
provide a strengthened understanding of the complex genetic mechanism of Tgf-β3-regulated palatogenesis. In
addition, we discussed the variations in gene expression in the absence of Tgf-β3 in HM implicated in cleft palate. Our results represent a comprehensive analysis of the gene profile in murine cleft palate due to the absence
of Tgf-β3. Further elucidation of the significantly up/downregulated genes will enhance our understanding of
the mechanisms controlling palate development, thereby paving the way for prevention of cleft palate during
development.

Methods

Animal selection and breeding.

Tgf-β3 heterozygous (+/−) C57BL/6J breeder mice were obtained from
Tom Doetschman (BIO5 Institute, University of Arizona, AZ). The reproduction and genotyping of Tgf-β3 −/−
mice was conducted as previously described9. Mice were accommodated and subject to procedures at the University of Nebraska Medical Center (UNMC) College of Dentistry Animal Facilities under the approval of the
UNMC Institution Animal Care and Use Committee (IACUC # 06–064). Null mutant embryos were generated
by intercrossing Tgf-β3 heterozygous male and female mice in a Mendelian fashion.

Genomic DNA purification and genotyping. Palatal tissues were dissected under the NIKON SMZ1000
stereo microscope system (NIKON, Tokyo, Japan) from embryos collected on embryonic day (E) 14.5 and E16.5
following the identification of vaginal plugs, which are considered to be E0.5. Palatal samples were stored in
RNAlater Stabilization Reagent (QIAGEN, Hilgen, Germany) to preserve the gene expression profile and individually labeled and matched with the corresponding tail tissue used for genotyping as detailed in our previous
study12.
Extraction of RNA, construction of small RNA libraries, and RNA‑Seq.

Two biological replicates
from each genotype and gestational stage were designed to ensure reproducibility and rule out the possibility
of differences caused by technical procedures. Palatal shelves were harvested in pairs from eight fetuses out of
four litters. Each sample consisted of two pairs of palatal shelves dissected from fetuses of the same genotype
from the same litter. The total RNA was purified using Arcturus PicoPure RNA Isolation Kit (THERMOFISHER
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Figure 3.  (A) IPA TGF-β signaling canonical pathway analysis overlaying the WT specific gene list: genes
significantly differentially expressed (adjusted p < 0.05) with a |FC|> 2.0 uniquely in WT, E16.5 versus E14.5.
Pink implies upregulation and green implies downregulation. Genes that are also involved in major non-Smad
pathways (ERK/MAPK, p38MAPK and PI3-AKT) in palatogenesis are indicated with links to the corresponding
pathways. (B) IPA TGF-β signaling canonical pathway analysis for the HM specific gene list: genes significantly
differentially expressed (adjusted p < 0.05) with a |FC|> 2.0 uniquely in HM, E16.5 versus E14.5. Green implies
downregulation. Genes that are also involved in major non-Smad pathways (ERK/MAPK, p38MAPK and PI3AKT) in palatogenesis are indicated with links to the corresponding pathways.
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Figure 4.  (A) Illustration of the level of mRNA expression showing fold change (log2) expression of the
WT gene mRNA comparative to reference control genes (18rSRNA, GAPDH, and β-actin). The bar heights
demonstrate mean expression of the genes in the WT samples. And the error bars suggest 95% confidence
interval estimates of the mean expressions. One asterisk designates statistically significant difference between the
means of a sample set in comparison to the mean of the control sample set (p value < 0.05); two asterisks indicate
statistically significant difference (p value < 0.01). (B) Illustration of the level of mRNA expression showing
fold change (log2) expression of HM gene mRNA comparative to reference control genes (18rSRNA, GAPDH,
and β-actin). The bar heights demonstrate mean expression of the genes in HM samples. And the error
bars suggest 95% confidence interval estimates of the mean expressions. One asterisk designates statistically
significant difference between the means of a sample set in comparison to the mean of the control sample set
(p value < 0.05); two asterisks indicate statistically significant difference (p value < 0.01).
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ENSEMBLE gene ID

Gene name

Adjusted p value

Fold change (HM E16.5/WT E16.5)

Function

26,908

Eif2s3y*

4.39E−76

16.75

Mutations associated with CLP147

20,592

Kdm5d*

2.35E−95

14.13

Mutations associated with palate
deformities148

22,290

Uty*

4.81E−45

8.69

Mutations associated with palate
deformities149

26,900

Ddx3y*

1.77E−25

5.78

Mutations associated with cleft
palate150
TGF-β signaling pathways target151

20,248

Serpinb3a

0.000523

2.15

Epithelial hyperplasia and
hyperkeratosis152,153

245,026

Col6a6*

0.001059

2.13

Epithelial hyperkeratosis154

16,682

Krt4

0.000106

2.09

Epithelial integrity gene155
Epithelial cell differentiation
modulator156

333,564

Fndc3c1

0.000915

2.02

Ectoderm differentiation gene146

57,294

Rps27*

0.000126

− 2.75

Mutations associated with cleft
palate157

Table 3.  Epithelial-specific genes that are significantly differentially expressed (adjusted p value < 0.05,
|FC|> 2.0) at E16.5 in HM versus WT. CLP, Cleft Lip and Palate; identified in mouse or in human (*).

SCIENTIFIC, San Francisco, CA) to reliably extract high-quality RNA from a few cells by following the manufacturer’s protocols. Purity and concentration were measured by ultraviolet spectroscopy (NANODROP, Wilmington, DE). The RNA integrity evaluation, construction of libraries, and validation was performed as described
in our previous study12.

RNA‑seq analysis. RNA-seq data was obtained for four groups: two genotypes, Tgf-β3 −/− HM and Tgf-

β3 +/+ WT samples, profiled at two time points, embryonic days E14.5 and E16.5. Each group was represented
by two biological replicates, resulting in eight samples. Each sample was run in two lanes on the ILLUMINA
HISEQ2000 next generation sequencer using the 2 × 101 bp paired-end mode. Due to the high correlation coefficient between them (r > 0.995) and in order to increase the coverage per biological sample and reduce the lane
effect45, lane data for each sample were pooled at the read level.
Raw reads were analyzed with FASTQC (V. 0.11.5) for quality control46. Overrepresented (e.g., adapter and
similar technical) sequences remaining in the raw reads were assessed and subsequently removed using TRIMMOMATIC (V. 0.36) in the palindrome mode based on default alignment detection and scoring parameters47.
Trimmomatic was also used for low quality base filtering. Maximum information quality filtering was employed
with a minimum average read quality threshold of 25. Following technical sequence and low-quality base
removal, reads that were shorter than 36 bp were filtered out.
Transcript quantification was done based on the GRCm38.p5 reference genome using Salmon (v. 0.8.2)
with default parameters48. Salmon uses sample-specific models, such as correction for GC-content bias, that
improve the accuracy of transcription abundance estimates. We used transcripts per million (TPM) in Salmon’s
output as the normalized relative abundance measure employed in our downstream analysis. Differential gene
expression analysis was done using DESeq2 (Love, Huber et al. 2014), which has been shown to perform well in
experimental designs with few r eplicates49. The RNA-seq data used in this paper were deposited under NCBI’s
Gene Expression Omnibus (GEO) database (Accession No.: GSE109838).
Clustering of samples and/or genes was done using the Unweighted Pair Group Method with Arithmetic Mean
(UPGMA) method (also known as hierarchical clustering) with Pearson’s correlation as the distance measure50.
The expression data matrix was row-normalized prior to the application of average linkage clustering. The Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.751 was used for functional analysis
of the gene lists, interrogating the Biological Process (BP), Molecular Function (MF), and Cellular Component
(CC) Gene Ontology (GO) categories52, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways53.
Biologically relevant categories that are overrepresented in the gene set and, therefore, may be of further interest
were assessed using the Expression Analysis Systematic Explorer (EASE) score in the DAVID tool. The EASE
score is the upper bound of the distribution of jackknife iterative resampling of Fisher’s exact probabilities with
Bonferroni multiple testing correction. Categories containing low numbers of genes are underweighted so that
the EASE score is more robust than the Fisher exact test. The EASE score is a significance level, with smaller
EASE scores indicating increasing confidence in overrepresentation. We selected GO categories that have EASE
scores of 0.05 or lower as significantly overrepresented.
We further analyzed the differentially expressed gene lists using the Ingenuity Pathway Analysis (IPA; QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis) software. IPA is based
on the manual curation of scientific literature to identify pathways, networks, and functional categories that are
significantly represented in the input gene l ist54. The computational analysis methods used in IPA are based on
enrichment approaches55,56 where pathways or functional groups in which the input gene lists are overrepresented
are identified. By the same token, IPA identifies upstream regulators (e.g., transcription factors, microRNAs,
kinases, compounds, or drugs) and generates interaction networks (based on known interactions identified in
the literature) that best explain the transcriptional changes observed in the input gene list.
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Confirmation of differentially expressed genes with qRT‑PCR.

To verify differentially expressed
genes in Tgf-β3 WT and HM samples, qRT-PCR was undertake as previously described19,57. Embryonic palates
were extracted from at E14.5 and E16.5, and RNA extraction was conducted as previously described19,57 using
Arcturus PicoPure RNA Isolation Kit (THERMOFISHER SCIENTIFIC, San Francisco, CA) to reliably extract
high-quality RNA from a few cells. RNA (500 ng) was converted to cDNA using Invitrogen Superscript IV VILO
Master Mix (THERMOFISHER SCIENTIFIC, San Francisco, CA) that generated a significant cDNA yield at
high temperatures in less time. An additional preamplification step was performed using TaqMan PreAmp Master Mix (THERMOFISHER SCIENTIFIC, San Francisco, CA) with a custom preamplification pool of genes of
interest to amplify small amounts of cDNA without introducing amplification bias. Samples were preamplified
for 14 cycles with thermal cycling conditions of 95 °C for 15 s and 60 °C for 4 min followed by immediate placement on ice. Finally, samples were diluted with TE buffer (ph 8.0) to 1:20 and were placed on 96-well custom
array plates in technical triplicate and qRT-PCR executed with TaqMan Fast Advanced Master Mix (THERMOFISHER SCIENTIFIC, San Francisco, CA) reagents. Polymerase chain reaction conditions were run in 40
cycles at 95 °C for 15 s, and 60 °C for 60 s. Following subtraction of technical repeat’s gene-specific ΔCtCt value
from the housekeeping gene’s ΔCtCt value, the data were, then, analyzed using analysis of variance (ANOVA) on
the repeat-normalized ΔΔCtCt values, including the control group; and translate effects were estimated from the
ANOVA onto the multiplicative scale. The values of 29 genes tested were normalized by adjusting for the concentration of established housekeeping gene, like 18S rRNA, glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
and β-actin and the ΔCt values of a naive/vehicle group.

Ethics approval and consent to participate. Tgf-β3 heterozygous (+/−) C57BL/6 J breeder mice were
obtained from Tom Doetschman (BIO5 Institute, University of Arizona, AZ). The reproduction and genotyping of Tgf-β3 −/− mice was conducted as previously d
 escribed9. The live mice experiments were performed in
accordance with the guidelines and regulations of the University of Nebraska Medical Center (UNMC) College
of Dentistry Animal Facilities under the approval of the UNMC Institution Animal Care and Use Committee
(IACUC # 18-088).

Data availability

The RNA-seq data used in this paper were deposited under NCBI’s Gene Expression Omnibus (GEO) database
(Accession No.: GSE109838).
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